{"id":"W4220682552","doi":"10.1158/1538-7445.sabcs21-p1-18-11","title":"Abstract P1-18-11: Analysis of first-line (1L) patients (pts) with de novo disease vs late relapse and all pts with vs without prior chemotherapy (CT) in the MONALEESA-3 (ML-3) trial","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Internal medicine; Adjuvant; Population; Cancer; Breast cancer; Fulvestrant; Placebo; Oncology; Nuclear medicine; Tamoxifen; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001126694,0.000261609,0.0006295549,0.0005447016,0.0002498296,0.00003279768,0.0003730865,0.00003911704,0.000716874],"category_scores_gemma":[0.00009446546,0.0001706959,0.00009939622,0.001827528,0.0004504429,0.0001362931,0.0001068449,0.0007878519,8.807991e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007311971,"about_ca_system_score_gemma":0.0006848069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001736067,"about_ca_topic_score_gemma":0.003752914,"domain_scores_codex":[0.9964775,0.0002523937,0.0003877124,0.0005960704,0.001637622,0.0006486879],"domain_scores_gemma":[0.9982106,0.0003177456,0.0001951768,0.0007026872,0.0002937985,0.0002800054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2703381,0.001341186,0.7063866,0.0002487299,0.001507579,0.0002712285,0.00351819,0.00579366,0.0004602605,0.00001469415,0.0001204044,0.009999352],"study_design_scores_gemma":[0.09035951,0.003570436,0.884864,0.0003403281,0.000851859,0.00001728593,0.000768327,0.0009518146,0.0003274282,0.00009314595,0.01749817,0.0003576734],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934747,0.001116637,0.00002305493,0.003173034,0.00003227791,0.00190526,0.0002039549,0.00002419719,0.00004694626],"genre_scores_gemma":[0.9971157,0.0004443808,0.0001421991,0.000571936,0.0001121367,0.001098766,0.00007083247,0.00007082491,0.0003732397],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1799786,"threshold_uncertainty_score":0.7849267,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05174704060359159,"score_gpt":0.3807966049095876,"score_spread":0.329049564305996,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}